New York Mobile Becomes First U.S. MVNO to Launch on Telness Tech’s Seamless OS
15.5.2025 15:00:00 CEST | Business Wire | Press release
New York Mobile is the first U.S. mobile virtual network operator (MVNO) to launch using Telness Tech’s newly launched Seamless OS platform. This deployment enables NY Mobile to deliver a next-generation wireless service, on T-Mobile’s largest and fastest 5G network. NY Mobile will be able to offer unprecedented features and flexibility for its customers including a vanity phone number marketplace and create-your-own-plan options.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515669016/en/
from the left; Jonas Cedenwing (Founder & CTO Telness Tech) Giovanni Perone, Co-Founder & CEO at New York Mobile. Location; One World Trade Center (NY Mobile HQ). Photo taken by Sebastian Stecki.
Customers can search and claim personalized phone numbers (including exclusive, previously exhausted area codes, creative number patterns, and words) through New York Mobile’s one-of-a-kind vanity number search engine and marketplace. This makes New York Mobile the first carrier to let both individuals and businesses choose their own never-before-used numbers. Create their own plan from scratch — adjusting data, features, and billing in real time.
"We approached this with very high expectations, demanding the best for our customers" said Giovanni Perone, Co-Founder and CEO of New York Mobile. "Telness Tech’s Seamless OS was the only platform that met our demands in customization. It let us build the fully digital, highly customized value proposition that we envisioned – from the vanity number marketplace to the custom plan builder – It gave us the flexibility to serve both individual and business customers without compromise."
New York Mobile is exactly the kind of visionary MVNO we designed Seamless OS to enable. The innovation — from vanity numbers to fully customized plans — is entirely theirs. Our role is to make sure nothing gets in their way. This launch shows what’s possible when our teltech meets bold ambition, concludes Founder and CTO of Telness Tech, Jonas Cedenwing.
The launch marks a major milestone for Telness Tech as NY Mobile is the first MVNO running Seamless OS with a fully customized value proposition. Seamless OS can launch and upgrade mobile operators, or even transform non-telco companies into mobile operators.
About New York Mobile
New York Mobile is a pioneering mobile virtual network operator specializing in personalized “vanity” phone numbers for consumers and businesses. It offers fully digital, customizable wireless plans with nationwide 5G coverage on the T-Mobile network. Learn more at nymobile.com.
About Telness Tech
Telness Tech is an international telecom software company founded in 2016 in Stockholm, Sweden. Its flagship product, Seamless OS, is a cloud-based BSS/OSS platform that enables mobile operators to launch fully digital, automated services. Seamless OS can even turn non-telco companies into mobile operators, powering them with connectivity. Telness Tech’s technology originated from the Swedish operator Telness – one of Europe’s highest-rated mobile operators – and now powers innovative operators across US, Europe and Africa. For more information, visit telnesstech.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250515669016/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom